Literature DB >> 7814622

Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina.

S J Kent1, L Corey, M B Agy, W R Morton, M J McElrath, P D Greenberg.   

Abstract

Macaca nemestrina has been described as an animal model for acute HIV-1 infection. This animal, unlike most infected humans, appears to contain HIV-1 replication. Therefore analysis of HIV-1-specific proliferative and cytotoxic T lymphocyte (CTL) responses following HIV-1 challenge of M. nemestrina may provide information into the role of such responses in both the control of acute HIV infection and protective immunity. Although CD4+ T cell responses to HIV-1 are generally difficult to detect in HIV-1-infected humans, early and persistent CD4+ T cell proliferative responses to HIV-1 antigens were detected in all HIV-1-inoculated M. nemestrina. HIV-1-specific CD8+ CTL responses were evaluated in PBMC by stimulation with autologous cells expressing HIV-1 genes, limiting dilution precursor frequency analysis, and T cell cloning. CTL reactive with gag, env, and nef were present 4-8 wk after infection, and persisted to 140 wk after infection. The presence of both CD4+ and CD8+ T cell responses before and after clearance of HIV-1 viremia is consistent with a role for these responses in the successful control of HIV-1 viral replication observed in M. nemestrina. Further studies of T cell immunity in these animals that resist disease should provide insights into the immunobiology of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814622      PMCID: PMC295418          DOI: 10.1172/JCI117647

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.

Authors:  S L Hu; B M Travis; V Stallard; K Abrams; L Misher; P Moran; J M Zarling; A J Langlois; L Kuller; W R Morton
Journal:  AIDS Res Hum Retroviruses       Date:  1992-08       Impact factor: 2.205

2.  Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.

Authors:  S K Kundu; T C Merigan
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

3.  HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.

Authors:  S L Rowland-Jones; D F Nixon; M C Aldhous; F Gotch; K Ariyoshi; N Hallam; J S Kroll; K Froebel; A McMichael
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

4.  Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins.

Authors:  S Lamhamedi-Cherradi; B Culmann-Penciolelli; B Guy; M P Kiény; F Dreyfus; A G Saimot; D Sereni; D Sicard; J P Lévy; E Gomard
Journal:  AIDS       Date:  1992-11       Impact factor: 4.177

5.  Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.

Authors:  F Hadida; A Parrot; M P Kieny; B Sadat-Sowti; C Mayaud; P Debre; B Autran
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 6.  Immunology of HIV infection.

Authors:  D E Lewis; J V Giorgi
Journal:  Int Rev Immunol       Date:  1990       Impact factor: 5.311

7.  Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.

Authors:  E L Cooney; M J McElrath; L Corey; S L Hu; A C Collier; D Arditti; M Hoffman; R W Coombs; G E Smith; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.

Authors:  T J Curiel; J T Wong; P F Gorczyca; R T Schooley; B D Walker
Journal:  AIDS Res Hum Retroviruses       Date:  1993-01       Impact factor: 2.205

9.  Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein.

Authors:  F Buseyne; M McChesney; F Porrot; S Kovarik; B Guy; Y Rivière
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.

Authors:  S Oehen; H Waldner; T M Kündig; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  11 in total

1.  Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.

Authors:  C Berger; M L Huang; M Gough; P D Greenberg; S R Riddell; H P Kiem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).

Authors:  Ai-Hua Lei; Gao-Hong Zhang; Ren-Rong Tian; Jia-Wu Zhu; Hong-Yi Zheng; Wei Pang; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2014-05

4.  Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.

Authors:  S J Kent; S L Hu; L Corey; W R Morton; P D Greenberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling.

Authors:  Katja Pekrun; Riri Shibata; Tatsuhiko Igarashi; Margaret Reed; Liana Sheppard; Philip A Patten; Willem P C Stemmer; Malcolm A Martin; Nay-Wei Soong
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques.

Authors:  Nichole R Klatt; Lauren A Canary; Thomas H Vanderford; Carol L Vinton; Jessica C Engram; Richard M Dunham; Heather E Cronise; Joanna M Swerczek; Bernard A P Lafont; Louis J Picker; Guido Silvestri; Jason M Brenchley
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

7.  Longitudinal analysis reveals characteristically high proportions of bacterial vaginosis-associated bacteria and temporal variability of vaginal microbiota in northern pig-tailed macaques (Macaca leonina).

Authors:  Lin Zhu; Ai-Hua Lei; Hong-Yi Zheng; Long-Bao Lyu; Zhi-Gang Zhang; Yong-Tang Zheng
Journal:  Dongwuxue Yanjiu       Date:  2015-09-18

8.  Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.

Authors:  S J Kent; A Zhao; S J Best; J D Chandler; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  A macaque model of HIV-1 infection.

Authors:  Theodora Hatziioannou; Zandrea Ambrose; Nancy P Y Chung; Michael Piatak; Fang Yuan; Charles M Trubey; Vicky Coalter; Rebecca Kiser; Doug Schneider; Jeremy Smedley; Rhonda Pung; Mercy Gathuka; Jacob D Estes; Ronald S Veazey; Vineet N KewalRamani; Jeffrey D Lifson; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

10.  Genotyping of TRIM5 locus in northern pig-tailed macaques (Macaca leonina), a primate species susceptible to Human Immunodeficiency Virus type 1 infection.

Authors:  Yi-Qun Kuang; Xia Tang; Feng-Liang Liu; Xue-Long Jiang; Ya-Ping Zhang; Guangxia Gao; Yong-Tang Zheng
Journal:  Retrovirology       Date:  2009-06-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.